Insulin like growth factor-1 (IGF-1) decreases ischemia-reperfusion induced apoptosis and necrosis in diabetic rats
✍ Scribed by Natalie N. Rizk; Javar Myatt-Jones; José Rafols; Joseph C. Dunbar
- Book ID
- 107571073
- Publisher
- Springer
- Year
- 2007
- Tongue
- English
- Weight
- 360 KB
- Volume
- 31
- Category
- Article
- ISSN
- 0969-711X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Recently, we have isolated a Chinese hamster cell variant (IV-A1 -j) resistant to an insulin-diphtheria-A chain toxic conjugate (Leckett and Germinario: Cytotechnology [in press]. This cell line exhibited a decreased level of insulin binding, but normal growth in serum-containing medium when compare
Multiple factors contribute to the growth retardation which is a characteristic feature of uncontrolled diabetes. In this report we have examined the effects of streptozotocin-induced (STZ) diabetes on expression of insulin-like growth factor-I (IGF-I) and insulin-like growth factor binding protein-
Wound healing, including re-epithelialization, is delayed in diabetes. Growth factors influence the healing process and amongst these, insulin-like growth factor (IGF) has been shown to stimulate keratinocyte proliferation in vitro. Monoclonal antibodies to insulin-like growth factors 1 and 2 (IGF1